日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587.

CXCR4肽拮抗剂LY2510924和单克隆抗体LY2624587可显著动员白细胞和造血干细胞

Peng Sheng-Bin, Van Horn Robert D, Yin Tinggui, Brown Robin M, Roell William C, Obungu Victor H, Ruegg Charles, Wroblewski Victor J, Raddad Eyas, Stille John R

LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys

LY2405319,一种工程化的FGF21变体,可改善糖尿病猴的代谢状况

Adams, Andrew C; Halstead, Carolyn A; Hansen, Barbara C; Irizarry, Armando R; Martin, Jennifer A; Myers, Sharon R; Reynolds, Vincent L; Smith, Holly W; Wroblewski, Victor J; Kharitonenkov, Alexei